article thumbnail

2023’s Most Impactful Hospice Deals

Hospice News

A rich mix of hospice merger and acquisition (M&A) activity at the end of 2023 is fueling trends into next year. Last month hospice, palliative and personal care provider Gentiva completed its acquisition of Promedica’s hospice, home health and palliative assets after inking the deal in March. NYSE: HUM) for $2.8

2023 278
article thumbnail

How Home Health, Personal Care Reimbursement Guiding Addus’ M&A Strategy

Hospice News

Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority. Addus provides hospice, home health and personal care to an estimated 47,500 patients annually across 203 locations in 22 states.

professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Most Significant Hospice Deals So Far in 2023

Hospice News

Thus far in 2023, hospice merger and acquisition activity has deviated from prior years. But in 2023, private equity activity slowed from its formerly frenzied pace. The majority of the 13 publicly announced hospice and home health deals in 2023 have involved “bolt-ons,” or smaller entities, Kulik stated. s (NYSE: HUM) $2.8

2023 244
article thumbnail

Addus Sees Hospice Improvements, Plans to Rebalance Home Health-Personal Care M&A Activity

Hospice News

Meanwhile, the company’s near-term acquisition sights are set more on home health than in personal care amid potential payment shifts. Pandemic forces winding down in hospice Addus provides home health, personal care and hospice to about 47,500 patients across roughly 203 locations in 22 states. million in revenue, a 2.6%

article thumbnail

Smaller Deals Likely to Reign in 2023 Hospice M&A

Hospice News

Though buyers remain hungry for hospice acquisitions, smaller deals will likely be the most prevalent during 2023. Deals 2023 Outlook Report. For 2023, it’s going to be at the same levels and possibly around the 150-transaction ballpark,” Kulik told Hospice News. The influence of changing PE trends. s (NYSE: HUM) $2.8

2023 227
article thumbnail

4 Ways Hospices Are Pursuing Growth in 2023

Hospice News

In 2023, the focus for many is to not only expand their core business but to spread further into the care continuum. The below comments were taken from original interviews, conducted in person and via the phone, throughout early 2023. In this story, Hospice News highlights the growth strategies of several providers.

2023 236
article thumbnail

Hospice M&A Takes Downturn in Early 2023, May Rebound in Second Half of the Year

Hospice News

Hospice merger and acquisition activity has taken a downturn in 2023, which is in line with projections from M&A experts. Approximately 14 hospice, home care and home health transactions were reported during the first quarter of 2023, according to recent data from Mertz Taggart. NYSE: HUM) for $2.8

2023 187